Q3 2023

Filed May 15, 2023 · 10-Q · 45 days after period end · 0000862668-23-000016

Q3 2023 · 10-Q

Revenue

$3.43M

+42.1% vs Q3 2022

Net Income

$585.24K

N/M vs Q3 2022

EPS Diluted

$0.04

N/M vs Q3 2022

Operating Income$589,550N/M

Operating Cash Flow

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$3.43M	$2.42M	$2.32M	$2.36M
Net Income	$585.24K	-$320.72K	-$137.47K	-$127.88K
EPS Diluted	$0.04	-$0.04	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR